Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,650.00
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST
-16.75%
Market Cap 726.28B
Revenue (ttm) 1.02T
Net Income (ttm) 46.58B
Shares Out 83.96M
EPS (ttm) 637.03
PE Ratio 13.58
Forward PE 12.17
Dividend 100.00 (1.16%)
Ex-Dividend Date Dec 27, 2024
Volume 58,777
Average Volume 100,762
Open 8,650.00
Previous Close 8,650.00
Day's Range 8,630.00 - 8,750.00
52-Week Range 7,680.00 - 12,870.00
Beta 0.59
RSI 54.78
Earnings Date Jul 29, 2025

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,533
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.

Financial Statements

News

There is no news available yet.